Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$1,024.09 USD
-20.57 (-1.97%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $1,023.90 -0.19 (-0.02%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/1/24 |
---|---|
Current Quarter | 10.57 |
EPS Last Quarter | 9.55 |
Last EPS Surprise | -6.37% |
ABR | 1.54 |
Earnings ESP
|
-3.13% |
---|---|
Current Year | 43.77 |
Next Year | 46.55 |
EPS (TTM) | 43.24 |
P/E (F1) | 23.40 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.39B | 3.62B | 13.97B | 14.99B |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 3.51B | 3.78B | 14.42B | 15.63B |
Low Estimate | 3.14B | 3.40B | 13.33B | 13.96B |
Year ago Sales | 3.16B | 3.36B | 13.12B | 13.97B |
Year over Year Growth Est. | 7.30% | 7.80% | 6.51% | 7.27% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.57 | 12.14 | 43.77 | 46.55 |
# of Estimates | 10 | 9 | 12 | 11 |
Most Recent Consensus | 8.90 | 9.69 | 38.82 | 41.00 |
High Estimate | 12.66 | 14.31 | 51.53 | 55.84 |
Low Estimate | 8.90 | 9.69 | 38.82 | 41.00 |
Year ago EPS | 10.24 | 11.59 | 43.79 | 43.77 |
Year over Year Growth Est. | 3.22% | 4.75% | -0.05% | 6.35% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 10.57 | 12.14 | 43.77 | 46.55 |
7 Days Ago | 10.57 | 12.14 | 43.77 | 46.55 |
30 Days Ago | 10.57 | 12.14 | 43.77 | 46.55 |
60 Days Ago | 10.71 | 12.22 | 44.06 | 46.91 |
90 Days Ago | 10.86 | 12.27 | 44.54 | 46.78 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 10.24 | 11.70 | 41.56 | 44.05 |
Zacks Consensus Estimate | 10.57 | 12.14 | 43.77 | 46.55 |
Earnings ESP | -3.13% | -3.65% | -5.04% | -5.37% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 9.55 | 11.86 | 11.59 | 10.24 | NA |
Estimate | 10.20 | 10.43 | 10.80 | 9.92 | NA |
Difference | -0.65 | 1.43 | 0.79 | 0.32 | 0.47 |
Surprise | -6.37% | 13.71% | 7.31% | 3.23% | 4.47% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more